TECHWIRE 30
(CIX: WRAL30)  918.74  up arrow+0.06  (0.01 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: Apple)  445.15  up arrow+3.01  (0.68 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: Quintiles)  45.03  up arrow+0.03  (0.07 %)  Updated: 06:40 PM EDT, May 24 2013
(OP: BASF SE)  95.14  down arrow-1.01  (-1.05 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: BioCryst)  1.59  down arrow-0.07  (-4.22 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: BioDelivery)  4.47  down arrow-0.03  (-0.67 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: CEMP)  7.13  up arrow+0.25  (3.63 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: Cisco Systems)  23.53  up arrow+0.02  (0.09 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: Cornerstone)  8.46  up arrow+0.05  (0.59 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: Cree)  59.08  down arrow-1.6  (-2.64 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: DARA)  0.73  down arrow-0.01  (-1.9 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: EMC Corp.)  23.65  down arrow-0.01  (-0.04 %)  Updated: 06:40 PM EDT, May 24 2013
(NQ: Extreme Networks)  3.46  up arrow+0.04  (1.17 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: Facebook)  24.31  down arrow-0.75  (-2.98 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: GlaxoSmithKline)  52.97  up arrow+0.24  (0.46 %)  Updated: 06:40 PM EDT, May 24 2013
(NQ: Google)  873.32  down arrow-9.47  (-1.07 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: IBM)  205.72  down arrow-0.44  (-0.21 %)  Updated: 06:40 PM EDT, May 24 2013
(NY: LH)  100.37  down arrow-0.34  (-0.34 %)  Updated: 06:40 PM EDT, May 24 2013
(OP: Lenovo Group)  19.88  up arrow+0.6  (3.09 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: MRK)  47.16  down arrow-0.17  (-0.36 %)  Updated: 06:40 PM EDT, May 24 2013
(NQ: Microsoft Corp)  34.27  up arrow+0.12  (0.35 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: NetApp)  36.45  down arrow-0.44  (-1.19 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: Novartis AG ADS)  74.36  up arrow+0.54  (0.73 %)  Updated: 06:40 PM EDT, May 24 2013
(OP: Novozymes A/S)  35.50  up arrow+0.4  (1.14 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: Pfizer)  29.04  down arrow-0.07  (-0.24 %)  Updated: 06:40 PM EDT, May 24 2013
(NQ: Pozen)  5.10  up arrow+0.17  (3.45 %)  Updated: 08:10 PM EDT, May 24 2013
(NY: Red Hat)  48.49  down arrow-0.87  (-1.76 %)  Updated: 06:40 PM EDT, May 24 2013
(NQ: BBRY)  14.48  up arrow+0.05  (0.35 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: Salix)  60.39  up arrow+0.7  (1.17 %)  Updated: 08:10 PM EDT, May 24 2013
(NQ: SQI)  23.86  up arrow+0.49  (2.1 %)  Updated: 08:10 PM EDT, May 24 2013

Posts tagged “PRA International”

Updated May 17

Premium Lock Raleigh-based PRA International eyes public offering

Another life science services firm in the Triangle, PRA International, may follow in the footsteps of a bigger rival - Quintiles - by offering stock in order to raise capital. Just two years ago, PRA was at the center of takeover rumors in the range of $1 billion.

PRA's corporate timeline PRA's corporate timeline

Updated March 6

Premium Lock PRA acquires ClinStar; Raleigh CRO boosts global reach

PRA logo Raleigh contract research organization PRA International, aiming to boost its capabilities to run global clinical trials, has acquired the Eastern Europe-focused CRO ClinStar.

Updated June 5, 2012

Premium Lock Pharma survey a split verdict for Quintiles, other service firms

Medical science Quintiles is tops in a survey of pharmaceutical firms. However, the report also finds disastisfaction also finds that nearly half would prefer to pick trial doctors to run studies rather than clinical research organizations such as Quintiles.

April 27, 2012

Premium Lock Raleigh firm PRA lands clinical trial deal with Amgen

PRA Intrernational PRA has entered into a strategic partnership with Amgen to do work on a series of phase 3 studies to develop biosimilar drugs. Biosimilars are follow-on biologic drugs that are cheaper than very expensive biologic drugs.

Updated December 26, 2011

Premium Lock What's on shopping list for CROs in the new year?

Biotech & Life Science Partners, M&A possibilities, sites in Asia, private equity investments and more consulting expertise are appealing items on the want lists for contract research organizations.

October 4, 2011

Premium Lock PRA International may be nearing sale topping $1B

PRA The Raleigh-based life science services firm is in the process of an "auction," according to The Wall Street Journal. If so, PRA would be the second regional contract research organization sold this fall. PPD is being sold for $3.9 billion.

July 18, 2011

Premium Lock PPD to explore 'unlocking value;' rumors send stock surging 10.3%

Fred Eshelman In a statement issued after a report about the company possibly being sold, Pharmaceutical Product Development says it management will "review" PPD's strategic plan and capital structure.

Updated July 18, 2011

Premium Lock PPD shares soar 17% on sale report; PRA on block, too?

PPD PRA International, which is based in Raleigh, and Pharmaceutical Product Development, which operates out of Wilmington, are looking for buyers, according to The Wall Street Journal.

June 15, 2011

Premium Lock PRA expands clinical research services in Sweden

PRA The Raleigh-based contract research organization operates some 40 offices worldwide.

Updated December 14, 2009

Premium Lock PRA International promotes its chief operating officer to top job

Colin Shannon Colin Shannon, a longtime executive at Pharmaceutical Product Development, will replace Terry Bieker as chief executive of PRA. Bieker, who is retiring, will remain a member of the contract research organization's board.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Jim Roberts
Entrepreneurship
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll

Videos

 
  • Allscripts bringing hundreds of jobs…

  • Nonprofit to handle NC economic…

  • Raleigh goes green, saves green with…

  • Gov. Pat McCrory speaks to NC Chamber

  • NC business leaders unveil job growth…

  • Investment expert: Leading is key in…

  • Retailers tout deals on Twitter

  • Vision for RTP: Social centerpiece